SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
16-Sep-24 12:14 PM View: | Archbold Brian David SVP Operations | Mesa Laboratories Inc. (MLAB) | 13-Sep-24 | Sale (Planned) | 1,499 | $125.00 | $187,375.00 | (100%) 1.5K to 0 | |
06-Sep-24 11:35 AM View: | Ladiwala Shiraz Shabanali Director | Mesa Laboratories Inc. (MLAB) | 01-Sep-24 | Option Exercise | 1,574 | -- | -- | 105% 1.5K to 3.07K | |
06-Sep-24 12:12 PM View: | Archbold Brian David SVP Operations | Mesa Laboratories Inc. (MLAB) | 01-Sep-24 | Payment of Exercise | 386 | $133.69 | $51,604.30 | (20%) 1.89K to 1.5K | |
06-Sep-24 12:46 PM View: | Sakys John V CFO | Mesa Laboratories Inc. (MLAB) | 01-Sep-24 | Option Exercise | 1,037 | -- | -- | 9% 11.56K to 12.6K | |
06-Sep-24 12:21 PM View: | Owens Gary M President and CEO | Mesa Laboratories Inc. (MLAB) | 01-Sep-24 | Option Exercise | 3,301 | -- | -- | 9% 34.99K to 38.29K | |
06-Sep-24 11:43 AM View: | Tripeny R Tony Director | Mesa Laboratories Inc. (MLAB) | 01-Sep-24 | Option Exercise | 1,074 | -- | -- | 67% 1.6K to 2.68K | |
06-Sep-24 11:22 AM View: | Alltoft Jennifer Sadie Director | Mesa Laboratories Inc. (MLAB) | 01-Sep-24 | Option Exercise | 1,074 | -- | -- | 45% 2.4K to 3.47K | |
06-Sep-24 12:12 PM View: | Archbold Brian David SVP Operations | Mesa Laboratories Inc. (MLAB) | 01-Sep-24 | Option Exercise | 845 | -- | -- | 81% 1.04K to 1.89K | |
06-Sep-24 11:53 AM View: | Sullivan John James Director | Mesa Laboratories Inc. (MLAB) | 01-Sep-24 | Option Exercise | 1,074 | -- | -- | 2% 71.58K to 72.66K | |
06-Sep-24 11:28 AM View: | Hall Shannon Director | Mesa Laboratories Inc. (MLAB) | 01-Sep-24 | Option Exercise | 1,074 | -- | -- | 63% 1.71K to 2.79K | |
06-Sep-24 12:46 PM View: | Sakys John V CFO | Mesa Laboratories Inc. (MLAB) | 01-Sep-24 | Payment of Exercise | 454 | $133.69 | $60,695.30 | (4%) 12.6K to 12.15K | |
06-Sep-24 12:21 PM View: | Owens Gary M President and CEO | Mesa Laboratories Inc. (MLAB) | 01-Sep-24 | Payment of Exercise | 1,445 | $133.69 | $193,182.00 | (4%) 38.29K to 36.85K | |
19-Aug-24 11:08 AM View: | Capone Mark Christopher Director | Mesa Laboratories Inc. (MLAB) | 15-Aug-24 | Option Exercise | 724 | -- | -- | 100% 0 to 0.72K | |
17-Jun-24 11:31 AM View: | Sakys John V CFO | Mesa Laboratories Inc. (MLAB) | 14-Jun-24 | Payment of Exercise | 572 | $91.60 | $52,395.20 | (5%) 12.13K to 11.56K | |
17-Jun-24 11:50 AM View: | Archbold Brian David SVP Operations | Mesa Laboratories Inc. (MLAB) | 14-Jun-24 | Payment of Exercise | 407 | $91.60 | $37,281.20 | (28%) 1.45K to 1.04K | |
17-Jun-24 11:31 AM View: | Sakys John V CFO | Mesa Laboratories Inc. (MLAB) | 14-Jun-24 | Option Exercise | 1,304 | -- | -- | 12% 10.83K to 12.13K | |
17-Jun-24 1:41 PM View: | Owens Gary M President and CEO | Mesa Laboratories Inc. (MLAB) | 14-Jun-24 | Option Exercise | 4,959 | -- | -- | 17% 30.03K to 34.99K | |
17-Jun-24 11:50 AM View: | Archbold Brian David SVP Operations | Mesa Laboratories Inc. (MLAB) | 14-Jun-24 | Option Exercise | 889 | -- | -- | 159% 0.56K to 1.45K | |
19-Dec-23 11:21 AM View: | Archbold Brian David SVP Operations | Mesa Laboratories Inc. (MLAB) | 15-Dec-23 | Sale (Planned) | 1,500 | $112.36 | $168,540.00 | (73%) 2.06K to 0.56K | |
14-Nov-23 6:11 AM View: | Sullivan John James Director | Mesa Laboratories Inc. (MLAB) | 09-Nov-23 | Gift | 200 | -- | -- | < 1% 73.58K to 73.78K | |
14-Nov-23 6:11 AM View: | Sullivan John James Director | Mesa Laboratories Inc. (MLAB) | 09-Nov-23 | Gift | 2,200 | -- | -- | (3%) 73.78K to 71.58K | |
19-Sep-23 12:34 PM View: | Schmieder John Bradley Director | Mesa Laboratories Inc. (MLAB) | 15-Sep-23 | Sale (Planned) | 1,000 | $123.74 | $123,740.00 | (2%) 63.76K to 62.76K | |
19-Sep-23 12:34 PM View: | Schmieder John Bradley Director | Mesa Laboratories Inc. (MLAB) | 14-Sep-23 | Sale (Planned) | 3,000 | $123.05 | $369,150.00 | (4%) 66.76K to 63.76K | |
14-Sep-23 1:47 PM View: | Schmieder John Bradley Director | Mesa Laboratories Inc. (MLAB) | 13-Sep-23 | Sale (Planned) | 3,000 | $123.32 | $369,965.00 | (4%) 69.76K to 66.76K | |
05-Sep-23 4:34 PM View: | Owens Gary M President and CEO | Mesa Laboratories Inc. (MLAB) | 01-Sep-23 | Planned Option Sale | 2,000 | $142.82 | $285,640.00 | (6%) 32.03K to 30.03K | |
05-Sep-23 4:34 PM View: | Owens Gary M President and CEO | Mesa Laboratories Inc. (MLAB) | 01-Sep-23 | Option Exercise | 2,000 | $136.42 | $272,840.00 | 7% 30.03K to 32.03K | |
16-Aug-23 3:54 PM View: | Tripeny R Tony Director | Mesa Laboratories Inc. (MLAB) | 15-Aug-23 | Option Exercise | 1,105 | -- | -- | 221% 0.5K to 1.6K | |
16-Aug-23 3:28 PM View: | Alltoft Jennifer Sadie Director | Mesa Laboratories Inc. (MLAB) | 15-Aug-23 | Option Exercise | 754 | -- | -- | 46% 1.65K to 2.4K | |
16-Aug-23 2:03 PM View: | Hall Shannon Director | Mesa Laboratories Inc. (MLAB) | 15-Aug-23 | Option Exercise | 754 | -- | -- | 79% 0.96K to 1.71K | |
16-Aug-23 3:45 PM View: | Ladiwala Shiraz Shabanali Director | Mesa Laboratories Inc. (MLAB) | 15-Aug-23 | Option Exercise | 1,055 | -- | -- | 260% 0.41K to 1.46K | |
16-Aug-23 3:19 PM View: | Schmieder John Bradley Director | Mesa Laboratories Inc. (MLAB) | 15-Aug-23 | Option Exercise | 754 | -- | -- | 1% 69.01K to 69.76K | |
16-Aug-23 3:37 PM View: | Sullivan John James Director | Mesa Laboratories Inc. (MLAB) | 15-Aug-23 | Option Exercise | 754 | -- | -- | 1% 72.83K to 73.58K | |
06-Sep-23 12:36 PM View: | Ladiwala Shiraz Shabanali Director | Mesa Laboratories Inc. (MLAB) | 15-Aug-23 | Option Exercise | 40 | -- | -- | 3% 1.46K to 1.5K | |
21-Jun-23 1:38 PM View: | Sullivan John James Director | Mesa Laboratories Inc. (MLAB) | 16-Jun-23 | Payment of Exercise | 6 | $135.55 | $813.30 | (< 1%) 72.84K to 72.83K | |
21-Jun-23 1:38 PM View: | Sullivan John James Director | Mesa Laboratories Inc. (MLAB) | 16-Jun-23 | Option Exercise | 15 | -- | -- | < 1% 72.82K to 72.84K | |
21-Jun-23 1:22 PM View: | Owens Gary M President and CEO | Mesa Laboratories Inc. (MLAB) | 16-Jun-23 | Payment of Exercise | 945 | $135.55 | $128,095.00 | (3%) 30.99K to 30.05K | |
21-Jun-23 12:23 PM View: | Archbold Brian David SVP Operations | Mesa Laboratories Inc. (MLAB) | 16-Jun-23 | Payment of Exercise | 189 | $135.55 | $25,619.00 | (8%) 2.25K to 2.06K | |
21-Jun-23 1:22 PM View: | Owens Gary M President and CEO | Mesa Laboratories Inc. (MLAB) | 16-Jun-23 | Option Exercise | 2,820 | -- | -- | 10% 28.17K to 30.99K | |
21-Jun-23 12:23 PM View: | Archbold Brian David SVP Operations | Mesa Laboratories Inc. (MLAB) | 16-Jun-23 | Option Exercise | 612 | -- | -- | 37% 1.64K to 2.25K | |
21-Jun-23 12:02 PM View: | Sakys John V CFO | Mesa Laboratories Inc. (MLAB) | 16-Jun-23 | Option Exercise | 848 | -- | -- | 8% 10.17K to 11.02K | |
21-Jun-23 12:02 PM View: | Sakys John V CFO | Mesa Laboratories Inc. (MLAB) | 15-Jun-23 | Payment of Exercise | 288 | $135.55 | $39,038.40 | (3%) 11.02K to 10.73K | |
27-Mar-23 9:40 AM View: | Sakys John V CFO | Mesa Laboratories Inc. (MLAB) | 24-Mar-23 | Option Exercise | 2,128 | $85.13 | $181,147.00 | 22% 9.8K to 11.92K | |
27-Mar-23 9:40 AM View: | Sakys John V CFO | Mesa Laboratories Inc. (MLAB) | 24-Mar-23 | Planned Option Sale | 2,128 | $167.01 | $355,397.00 | (18%) 11.92K to 9.8K | |
27-Mar-23 9:40 AM View: | Sakys John V CFO | Mesa Laboratories Inc. (MLAB) | 22-Mar-23 | Option Exercise | 2,500 | $122.66 | $306,650.00 | 26% 9.8K to 12.3K | |
27-Mar-23 9:40 AM View: | Sakys John V CFO | Mesa Laboratories Inc. (MLAB) | 22-Mar-23 | Planned Option Sale | 2,500 | $171.62 | $429,050.00 | (20%) 12.3K to 9.8K | |
16-Mar-23 10:00 PM View: | Sakys John V CFO | Mesa Laboratories Inc. (MLAB) | 15-Mar-23 | Planned Option Sale | 1,000 | $165.71 | $165,710.00 | (9%) 10.8K to 9.8K | |
16-Mar-23 10:00 PM View: | Sakys John V CFO | Mesa Laboratories Inc. (MLAB) | 15-Mar-23 | Option Exercise | 1,000 | $70.56 | $70,560.00 | 10% 9.8K to 10.8K | |
09-Mar-23 6:13 PM View: | Sakys John V CFO | Mesa Laboratories Inc. (MLAB) | 09-Mar-23 | Option Exercise | 400 | $70.56 | $28,224.00 | 4% 9.8K to 10.2K | |
09-Mar-23 6:13 PM View: | Sakys John V CFO | Mesa Laboratories Inc. (MLAB) | 09-Mar-23 | Planned Option Sale | 400 | $169.97 | $67,988.00 | (4%) 10.2K to 9.8K | |
09-Feb-23 8:04 PM View: | Sakys John V CFO | Mesa Laboratories Inc. (MLAB) | 09-Feb-23 | Option Exercise | 1,000 | $51.85 | $51,850.00 | 10% 9.8K to 10.8K |